Lenvervimab

Lenvervimab
Monoclonal antibody
Type	?
Source	Humanized
Target	hepatitis B virus surface antigen
Clinical data
Other names	GC1102
ATC code	none;
Identifiers
CAS Number	2055006-79-4;
UNII	FX9X4L2A2L;
E number	{{#property:P628}}
CompTox Dashboard (EPA)	{{#property:P3117}}Lua error in Module:EditAtWikidata at line 29: attempt to index field 'wikibase' (a nil value).;
ECHA InfoCard	{{#property:P2566}}Lua error in Module:EditAtWikidata at line 29: attempt to index field 'wikibase' (a nil value).

Lenvervimab (INN;^[1] development code GC1102) is a monoclonal antibody that is being investigated for hepatitis B.^[2]

This drug is being developed by GC Pharma. As of 2018^[update], lenvervimab is undergoing Phase II/III trials.

References

^ Lua error in Module:Citation/CS1/Configuration at line 2172: attempt to index field '?' (a nil value).
^ Lua error in Module:Citation/CS1/Configuration at line 2172: attempt to index field '?' (a nil value).

This monoclonal antibody–related article is a stub. You can help Wikipedia by expanding it.